These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10990126)

  • 21. PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.
    Welte M; Zwissler B; Habazettl H; Messmer K
    Eur Surg Res; 1993; 25(5):329-40. PubMed ID: 8404993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are inhaled vasodilators useful in acute lung injury and acute respiratory distress syndrome?
    Siobal MS; Hess DR
    Respir Care; 2010 Feb; 55(2):144-57; discussion 157-61. PubMed ID: 20105341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective pulmonary vasodilation induced by aerosolized zaprinast.
    Ichinose F; Adrie C; Hurford WE; Bloch KD; Zapol WM
    Anesthesiology; 1998 Feb; 88(2):410-6. PubMed ID: 9477062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.
    Nahar K; Rashid J; Absar S; Al-Saikhan FI; Ahsan F
    Pharm Res; 2016 Jul; 33(7):1696-710. PubMed ID: 27048347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficiency of aerosolized nitric oxide donor drugs to achieve sustained pulmonary vasodilation.
    Schütte H; Grimminger F; Otterbein J; Spriestersbach R; Mayer K; Walmrath D; Seeger W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):985-94. PubMed ID: 9262367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
    Welte M; Zwissler B; Habler O; Kleen M; Messmer K
    Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled nitric oxide in neonates with persistent pulmonary hypertension.
    Tworetzky W; Bristow J; Moore P; Brook MM; Segal MR; Brasch RC; Hawgood S; Fineman JR
    Lancet; 2001 Jan; 357(9250):118-20. PubMed ID: 11197402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled nitric oxide attenuates bronchoconstriction in canine peripheral airways.
    Gwyn DR; Lindeman KS; Hirshman CA
    Am J Respir Crit Care Med; 1996 Feb; 153(2):604-9. PubMed ID: 8564105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
    Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
    J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of alteration of endogenous nitric oxide pathway during prolonged nitric oxide inhalation in intensive care unit patients.
    Lukaszewicz AC; Mebazaa A; Callebert J; Matéo J; Gatecel C; Kechiche H; Maistre G; Carayon A; Baudin B; Payen D
    Crit Care Med; 2005 May; 33(5):1008-14. PubMed ID: 15891329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension.
    Adrie C; Ichinose F; Holzmann A; Keefer L; Hurford WE; Zapol WM
    J Appl Physiol (1985); 1998 Feb; 84(2):435-41. PubMed ID: 9475849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension.
    Brilli RJ; Krafte-Jacobs B; Smith DJ; Passerini D; Moore L; Ballard ET
    Crit Care Med; 1998 Aug; 26(8):1390-6. PubMed ID: 9710099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled prostanoids in the therapy of pulmonary hypertension.
    Gessler T; Seeger W; Schmehl T
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):1-12. PubMed ID: 18518827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled nitric oxide--from pollutant to patent.
    Quinn AC; Vallance P
    Eur J Clin Invest; 1993 Aug; 23(8):445-7. PubMed ID: 8404994
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhaled nitric oxide and bronchopulmonary dysplasia.
    Steinhorn RH; Shaul PW; deRegnier RA; Kennedy KA
    Pediatrics; 2011 Jul; 128(1):e255-6; author reply e256-7. PubMed ID: 21725058
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhaled nitric oxide: a magic bullet?
    Higenbottam T
    Q J Med; 1993 Sep; 86(9):555-8. PubMed ID: 8255969
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhaled Therapies for Pulmonary Hypertension.
    Hill NS; Preston IR; Roberts KE
    Respir Care; 2015 Jun; 60(6):794-802; discussion 802-5. PubMed ID: 26070575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled nitric oxide delivery systems.
    Troncy E; Francoeur M; Blaise G
    Anesthesiology; 1997 Dec; 87(6):1591-3. PubMed ID: 9416754
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhaled nitric oxide for preterm infants.
    Truog WE; Martin RJ; Ballard RA; Black D; Cnaan A;
    Pediatrics; 2008 Jun; 121(6):1287-8; author reply 1288-9. PubMed ID: 18519502
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhaled nitric oxide in inhalation injury.
    Sheridan RL; Hess D
    J Burn Care Res; 2009; 30(1):162-4. PubMed ID: 19060730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.